Sponsors

New integrated chemistry and immunoassay analyser

Beckman Coulter Diagnostics has launched its new DxC 500i integrated clinical chemistry and immunoassay analyser. Ideally suited for satellite and independent laboratories, the DxC 500i offers flexibility, scalability and data commutability with an extensive assay menu.

Utilising Beckman Coulter's common reagents and consumables across its scalable clinical chemistry and immunoassay portfolio, the DxC 500i analyser enables commutable patient results, offering hospitals and healthcare networks strategic benefits in patient care and inventory management.

"The development of the DxC 500i analyser is yet another example of how Beckman Coulter is investing in the needs of a broad range of laboratories across healthcare systems," said Kathleen Orland, Senior Vice President, Business Unit, General Manager, Chemistry and Immunoassay for Beckman Coulter Diagnostics. "The DxC 500i powers both clinical chemistry and immunoassay testing in one space-saving package. With steadfast performance, practical simplicity, and trusted clinical quality, this analyser meets the specific demands of the low-volume laboratory customer, standalone laboratories and community hospitals."

The DxC 500i features FlexMode operations, prioritising immunoassay and chemistry testing according to each sample's urgency. The new dynamic sample handler manages repeats and re-runs without operator intervention and pulls in a new sample rack as soon as the previous rack is offloaded, optimising rapid throughput in a compact footprint. Of equal importance, the DxC 500i's intuitive interface supports even the newest users through proactive task indicators, step-by-step instructions and simplified staff onboarding and training.

In January, Beckman Coulter unveiled the DxC 500 AU, an automated clinical chemistry analyser with onboard guided workflows, more than 120 assays, and standardized reagents for use across healthcare networks. The DxC 500i analyser incorporates the DxC 500 AU technology within its clinical chemistry capabilities, including its Six Sigma performance. The DxC 500i is currently available in countries accepting the CE mark.

 

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024